New database lets marketers make house calls to docs

Share this article:

Healthcare Data Solutions (HDS) launched a new database providing home addresses and personal email account listings for physicians, dentists, nurses and other healthcare providers.

The database, called PrescriberPRO@Home, includes 190,000 home email addresses that are CAN-SPAM compliant, and half a million postal addresses that have been validated by the USPS, according to a statement.

Chris Lundgren, VP of sales at HDS, said product development at the company is driven by customer requests, adding that healthcare recruiters and publications in particular have expressed a need for home addresses and personal email lists.

The new database also helps HDS keep their physicians' office data — the company's "bread and butter," according to Lundgren — current, since doctors aren't likely to file a national change of address when they switch practices or move to a new office, but they would if their home address changed.

Lundgren said personal email address are often captured when doctors sign up to attend events or receive services, and many of HDS's clients already have the information.  "We clean up and enhance our clients' customer files for them," Lundgren said, adding that many customer files HDS receives for sprucing already contain personal email accounts and home addresses.

The PrescriberPRO@Home database allows marketers to sort results based on practice name, group or hospital affiliation, license information, specialty and other categories, the statement said.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...